317 filings
Page 2 of 16
8-K
yl709jg0b 6w24sl
21 Oct 22
Amendments to Articles of Incorporation or Bylaws
4:34pm
8-K
s6zz65qyv
6 Sep 22
Results of Operations and Financial Condition
4:22pm
8-K
pq36 m3axpu
14 Jul 22
Departure of Directors or Certain Officers
5:05pm
8-K
9zy3hi3jzn1lih
29 Jun 22
Avid Bioservices Reports Financial Results for Fourth Quarter and
4:16pm
8-K
2ut5ah
8 Mar 22
Results of Operations and Financial Condition
4:25pm
8-K
fpc042jr4v4
10 Jan 22
Avid Bioservices Announces Official Opening of Second Downstream Processing Suite Within Myford North Facility
4:54pm
8-K
918h 3zf92v
7 Dec 21
Results of Operations and Financial Condition
4:23pm
8-K
c1pbul r0
4 Nov 21
Avid Bioservices Appoints Elie G. Hanania, Ph.D., as Vice President, Process Development, Viral Vector Technologies
4:46pm
8-K
35vbdeq
26 Oct 21
Other Events
4:55pm
8-K
qpq40gtb3b ro
22 Oct 21
Departure of Directors or Certain Officers
4:49pm
8-K
q5ni9ajx
14 Oct 21
AVID BIOSERVICES announces expansion into viral vector development and manufacturing services for cell and gene therapy
5:11pm
8-K
bek 8vvbb
8 Oct 21
Avid Bioservices Appoints Matthew Kwietniak as Chief Commercial Officer
4:51pm
8-K
e57i8wf
8 Sep 21
Results of Operations and Financial Condition
4:24pm
8-K
fow1w1w
14 Jul 21
Departure of Directors or Certain Officers
5:00pm
8-K
pss2e enee
7 Jul 21
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
hjrmxq0umk1wumvaq
1 Jul 21
Avid Bioservices Announces Appointment of esther m. alegria, ph.d., to Board of Directors
4:05pm
8-K
3to7hzbkd 3rt
29 Jun 21
Results of Operations and Financial Condition
4:21pm
8-K
3t2z z4dtlqcs
5 May 21
Entry into a Material Definitive Agreement
12:00am
8-K
a5y9no13i483m
15 Apr 21
Avid Bioservices Announces Completion of Redemption of Series E Convertible Preferred Stock
5:07pm
8-K
5k52j8ef7egek75s
12 Mar 21
Avid Bioservices, Inc. Announces Proposed $125 Million Offering of Exchangeable Senior Notes
4:53pm